Testing a pharmacy genetic decision tool to reduce disparities
This trial tests whether a “point-of-care” computer tool can help clinicians use a person’s genetic information to choose safer, better medication decisions. It focuses on helping reduce treatment differences for African American patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must self-identify as African American
- You cannot be dealing with a current or planned liver or kidney transplant
- You cannot have active or past leukemia
- You must be able to understand the study and agree to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
This study looks at how to put genetic testing results (pharmacogenomics) into regular doctor care. It aims to see whether using the results helps doctors choose safer, better-matched medications.
This study looks at genetic markers (genes) related to kidney risk in Black/African American adults. It may help researchers better understand who is at higher risk and how genetics could guide future care.
This study helps doctors use genetic (pharmacogenomic) testing to choose which medicines may work best and cause fewer side effects. You may join if your child’s doctor is considering certain common medicines, such as pain, antibiotic, or mental health medications.
This trial checks if genetic testing can help doctors pick safer drugs for you when you are in the hospital or visiting a clinic. If you qualify, you will give a cheek swab and be followed for about 12 weeks.
This study offers free genetic testing to Black or African American people who have had certain cancers. It aims to find inherited gene changes that increase cancer risk and improve health equity.
Hear when a new Information Seeking Behavior trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.